Stoke Therapeutics, Inc. — Investor Relations & Filings
Stoke Therapeutics, Inc. is a biotechnology company focused on developing treatments for severe genetic diseases by addressing their underlying cause. The company utilizes its proprietary research platform, TANGO (Targeted Augmentation of Nuclear Gene Output), an RNA-based approach designed to restore protein levels. This technology works by upregulating protein expression from the healthy copy of a gene to compensate for a mutated or non-functioning copy, a mechanism particularly suited for haploinsufficient diseases. Stoke's lead investigational medicine, zorevunersen (STK-001), is in late-stage clinical development for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company is also advancing its platform to treat other genetic conditions, including autosomal dominant optic atrophy (ADOA).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-09-23 | English | |
| Major Shareholding Notification 2024 | 2024-09-23 | English | |
| Regulatory Filings 2024 | 2024-09-19 | English | |
| 8-K | 2024-09-10 | English | |
| Director's Dealing 2024 | 2024-09-05 | English | |
| 10-Q | 2024-08-07 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 12826501 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-09-23 | English | ||
| 12826502 | Major Shareholding Notification 2024 | 2024-09-23 | English | ||
| 12826503 | Regulatory Filings 2024 | 2024-09-19 | English | ||
| 12826504 | 8-K | 2024-09-10 | English | ||
| 12826505 | Director's Dealing 2024 | 2024-09-05 | English | ||
| 12826506 | 10-Q | 2024-08-07 | English | ||
| 12826507 | 8-K | 2024-08-07 | English | ||
| 12826508 | Director's Dealing 2024 | 2024-08-05 | English | ||
| 12826509 | Regulatory Filings 2024 | 2024-08-01 | English | ||
| 12826510 | Major Shareholding Notification 2024 | 2024-07-08 | English | ||
| 12826511 | Director's Dealing 2024 | 2024-07-03 | English | ||
| 12826512 | Director's Dealing 2024 | 2024-07-03 | English | ||
| 12826513 | Regulatory Filings 2024 | 2024-07-02 | English | ||
| 12826514 | 8-K | 2024-06-21 | English | ||
| 12826515 | Regulatory Filings 2024 | 2024-06-21 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Stoke Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32172/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32172 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32172 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32172 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32172}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Stoke Therapeutics, Inc. (id: 32172)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.